Medicalg
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cuttin… Read more
Medicalg (MDG) - Net Assets
Latest net assets as of September 2025: zł65.90 Million PLN
Based on the latest financial reports, Medicalg (MDG) has net assets worth zł65.90 Million PLN as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł105.91 Million) and total liabilities (zł40.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł65.90 Million |
| % of Total Assets | 62.22% |
| Annual Growth Rate | 26.63% |
| 5-Year Change | -62.78% |
| 10-Year Change | -22.18% |
| Growth Volatility | 153.82 |
Medicalg - Net Assets Trend (2010–2024)
This chart illustrates how Medicalg's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medicalg (2010–2024)
The table below shows the annual net assets of Medicalg from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł77.19 Million | -16.62% |
| 2023-12-31 | zł92.57 Million | +15.59% |
| 2022-12-31 | zł80.08 Million | +68.96% |
| 2021-12-31 | zł47.39 Million | -77.14% |
| 2020-12-31 | zł207.37 Million | -7.72% |
| 2019-12-31 | zł224.72 Million | -2.62% |
| 2018-12-31 | zł230.76 Million | +13.27% |
| 2017-12-31 | zł203.73 Million | -5.22% |
| 2016-12-31 | zł214.95 Million | +116.71% |
| 2015-12-31 | zł99.19 Million | +9.25% |
| 2014-12-31 | zł90.79 Million | +12.19% |
| 2013-12-31 | zł80.93 Million | +9.63% |
| 2012-12-31 | zł73.82 Million | +521.22% |
| 2011-12-31 | zł11.88 Million | +319.97% |
| 2010-12-31 | zł2.83 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medicalg's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13259963382.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł995.00K | 1.29% |
| Other Comprehensive Income | zł-1.34 Million | -1.74% |
| Other Components | zł210.98 Million | 273.38% |
| Total Equity | zł77.17 Million | 100.00% |
Medicalg Competitors by Market Cap
The table below lists competitors of Medicalg ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gemina Laboratories Ltd
OTCQB:GLABF
|
$34.29 Million |
|
Electrocore LLC
NASDAQ:ECOR
|
$34.30 Million |
|
Silver One Resources Inc
OTCQX:SLVRF
|
$34.30 Million |
|
Sotherly Hotels Inc
NASDAQ:SOHO
|
$34.31 Million |
|
Archer Materials Limited
PINK:ARRXF
|
$34.27 Million |
|
YAS Co., Ltd.
KQ:255440
|
$34.26 Million |
|
Top High Image
TWO:3284
|
$34.25 Million |
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
$34.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medicalg's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 92,557,000 to 77,174,000, a change of -15,383,000 (-16.6%).
- Net loss of 16,081,000 reduced equity.
- Other comprehensive income increased equity by 698,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-16.08 Million | -20.84% |
| Other Comprehensive Income | zł698.00K | +0.9% |
| Other Changes | zł-1.00 | -0.0% |
| Total Change | zł- | -16.62% |
Book Value vs Market Value Analysis
This analysis compares Medicalg's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.69x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 25.24x to 3.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | zł1.14 | zł28.65 | x |
| 2011-12-31 | zł4.77 | zł28.65 | x |
| 2012-12-31 | zł25.67 | zł28.65 | x |
| 2013-12-31 | zł23.65 | zł28.65 | x |
| 2014-12-31 | zł26.27 | zł28.65 | x |
| 2015-12-31 | zł28.70 | zł28.65 | x |
| 2016-12-31 | zł49.06 | zł28.65 | x |
| 2017-12-31 | zł46.83 | zł28.65 | x |
| 2018-12-31 | zł52.64 | zł28.65 | x |
| 2019-12-31 | zł54.29 | zł28.65 | x |
| 2020-12-31 | zł50.11 | zł28.65 | x |
| 2021-12-31 | zł10.42 | zł28.65 | x |
| 2022-12-31 | zł16.61 | zł28.65 | x |
| 2023-12-31 | zł17.50 | zł28.65 | x |
| 2024-12-31 | zł7.75 | zł28.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medicalg utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -67.00%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.37x
- Recent ROE (-20.84%) is below the historical average (-15.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 67.51% | 46.50% | 1.12x | 1.30x | zł1.63 Million |
| 2011 | 25.30% | 51.78% | 0.43x | 1.13x | zł1.82 Million |
| 2012 | 10.08% | 67.86% | 0.15x | 1.02x | zł57.08K |
| 2013 | 13.44% | 69.27% | 0.19x | 1.03x | zł2.78 Million |
| 2014 | 16.00% | 48.89% | 0.31x | 1.05x | zł5.45 Million |
| 2015 | 14.04% | 28.23% | 0.48x | 1.03x | zł4.01 Million |
| 2016 | 22.66% | 31.35% | 0.35x | 2.09x | zł22.41 Million |
| 2017 | 15.12% | 12.56% | 0.70x | 1.71x | zł8.65 Million |
| 2018 | 7.59% | 7.23% | 0.63x | 1.66x | zł-4.57 Million |
| 2019 | -0.15% | -0.17% | 0.61x | 1.45x | zł-19.88 Million |
| 2020 | -6.23% | -11.56% | 0.39x | 1.37x | zł-33.65 Million |
| 2021 | -381.21% | -373.61% | 0.42x | 2.41x | zł-185.38 Million |
| 2022 | -12.53% | -18.91% | 0.58x | 1.15x | zł-21.33 Million |
| 2023 | -0.62% | -1.34% | 0.35x | 1.31x | zł-9.83 Million |
| 2024 | -20.84% | -67.00% | 0.23x | 1.37x | zł-23.80 Million |
Industry Comparison
This section compares Medicalg's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $16,415,738
- Average return on equity (ROE) among peers: -200.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medicalg (MDG) | zł65.90 Million | 67.51% | 0.61x | $34.29 Million |
| Adiuvo Investment SA (ADV) | $7.30 Million | -237.44% | 6.75x | $685.90K |
| Braster S.A. (BRA) | $650.00K | -601.08% | 36.39x | $2.89 Million |
| Genomtec S.A. (GMT) | $7.57 Million | -144.47% | 0.24x | $14.99 Million |
| Medinice S.A (ICE) | $8.23 Million | -27.31% | 0.42x | $49.49 Million |
| Synektik S.A. (SNT) | $58.33 Million | 6.18% | 0.83x | $268.09 Million |